[go: up one dir, main page]

ITMI20030762A1 - HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS. - Google Patents

HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.

Info

Publication number
ITMI20030762A1
ITMI20030762A1 ITMI20030762A ITMI20030762A1 IT MI20030762 A1 ITMI20030762 A1 IT MI20030762A1 IT MI20030762 A ITMI20030762 A IT MI20030762A IT MI20030762 A1 ITMI20030762 A1 IT MI20030762A1
Authority
IT
Italy
Prior art keywords
crystallization process
bupropion
hydrochloride
hydrochloride bupropion
crystallization
Prior art date
Application number
Other languages
Italian (it)
Inventor
Luca Florindo De
Massimo Ferrari
Fiorella Lombardi
Original Assignee
Erregierre Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erregierre Spa filed Critical Erregierre Spa
Priority to ITMI20030762 priority Critical patent/ITMI20030762A1/en
Priority to PCT/EP2004/050495 priority patent/WO2004089873A1/en
Priority to CA002549350A priority patent/CA2549350A1/en
Publication of ITMI20030762A1 publication Critical patent/ITMI20030762A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ITMI20030762 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS. ITMI20030762A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI20030762 ITMI20030762A1 (en) 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.
PCT/EP2004/050495 WO2004089873A1 (en) 2003-04-11 2004-04-09 Process for crystallising bupropion hydrochloride
CA002549350A CA2549350A1 (en) 2003-04-11 2004-04-09 Process for crystallising bupropion hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20030762 ITMI20030762A1 (en) 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.

Publications (1)

Publication Number Publication Date
ITMI20030762A1 true ITMI20030762A1 (en) 2004-10-12

Family

ID=33156348

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI20030762 ITMI20030762A1 (en) 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.

Country Status (3)

Country Link
CA (1) CA2549350A1 (en)
IT (1) ITMI20030762A1 (en)
WO (1) WO2004089873A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
WO2008099418A2 (en) * 2007-02-12 2008-08-21 Alembic Limited An improved process for preparing bupropion hydrochloride
US11969421B2 (en) 2013-11-05 2024-04-30 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11534414B2 (en) 2013-11-05 2022-12-27 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11433067B2 (en) 2013-11-05 2022-09-06 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US12109178B2 (en) 2013-11-05 2024-10-08 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US12194006B2 (en) 2013-11-05 2025-01-14 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
CN106431943B (en) * 2016-09-13 2021-03-26 迪嘉药业集团有限公司 Preparation method of bupropion hydrochloride crystal
US12433884B2 (en) 2020-06-05 2025-10-07 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
US12472156B2 (en) 2020-06-05 2025-11-18 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
AU2021390502A1 (en) 2020-12-01 2023-06-22 Antecip Bioventures Ii Llc Bupropion and dextromethorphan for reduction of suicide risk in depression patients
US12156914B2 (en) 2022-06-30 2024-12-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising bupropion and cysteine
US11717518B1 (en) 2022-06-30 2023-08-08 Antecip Bioventures Ii Llc Bupropion dosage forms with reduced food and alcohol dosing effects
US20240000729A1 (en) * 2022-06-30 2024-01-04 Axsome Therapeutics, Inc. Microparticles containing bupropion
US12036191B1 (en) 2022-06-30 2024-07-16 Antecip Bioventures Ii Llc Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
US11844797B1 (en) 2023-04-20 2023-12-19 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression
US12194036B2 (en) 2022-07-07 2025-01-14 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression
US11730706B1 (en) 2022-07-07 2023-08-22 Antecip Bioventures Ii Llc Treatment of depression in certain patient populations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759838A (en) * 1969-12-04 1971-06-03 Wellcome Found KETONES WITH BIOLOGICAL ACTIVITY
US6238697B1 (en) * 1998-12-21 2001-05-29 Pharmalogix, Inc. Methods and formulations for making bupropion hydrochloride tablets using direct compression
US6306436B1 (en) * 2000-04-28 2001-10-23 Teva Pharmaceuticals Usa, Inc. Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

Also Published As

Publication number Publication date
WO2004089873A1 (en) 2004-10-21
CA2549350A1 (en) 2005-10-21

Similar Documents

Publication Publication Date Title
ITMI20030762A1 (en) HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.
NO2015003I1 (en) bupropion
DE602004023295D1 (en) MANUFACTURING PROCESS FOR CAPS
BR0211391B1 (en) process for preparing 4-aminodiphenylamines.
ITBS20030049A1 (en) ANGULAR PNEUMATIC CLAMP STRUCTURE.
ITMI20050817A1 (en) DEALOGENATION PROCESS
ITMI20030444A1 (en) PROCESS TO PREPARE (PER) FLUOROALOGENOETERI.
ITRM20030083A0 (en) GLASSES FRAME.
ITMI20050383A1 (en) PROCESS FOR PREPARING PEROXIDE PERFLUOROPOLIETERS
ITMI20030150A1 (en) PROCESS TO PREPARE FLUOROALOGENOETERI.
ITMI20032165A1 (en) GABAPENTINE PREPARATION PROCESS
ITMI20041920A1 (en) PROCESS FOR THE PREPARATION OF N, N-DIISOPROPYL-3-2-HYDROXY-5-METHYLPHENYL-3-PHENYL-PROPABAMMINE
ATE355060T1 (en) 2-METHOXYMETHYL-3-(3,4-DICHLOROPHENYL)-8- AZABICYCLO (3.2.1)OCTANTARTRATE SALTS
ITFI20030275A1 (en) PROCESS FOR GALACTOSE PREPARATION
BRPI0408548B1 (en) process for preparing atypical articles.
ITMI20040873A1 (en) 3-3.4 METHYLENEIXY-FENYL-2-METHYLPROPANAL PREPARATION PROCESS
ITMI20032059A1 (en) PROCESS FOR THE PREPARATION OF DOXIFLURIDINE.
ITMI20030823A1 (en) ALCOHOS AND ARYOXYPHENOL PREPARATION PROCESS.
ITMI20032185A1 (en) PROCESS FOR THE SYNTHESIS OF CATIONIC LIPIDS.
ITMI20021732A1 (en) PROCESS FOR PREPARING PEARLS.
DE10358553B8 (en) Pliers, especially pliers
ITSA20040012A1 (en) STERILIZATION PROCESS OF A GLUCOCORTICOSTEROID.
ITMI20022771A1 (en) HYDRAZINE ARILATION PROCESS.
ITMI20031298A1 (en) PREPARATION PROCESS FOR MODAFINIL POLYMORPHIC FORM (I).
BRPI0617924A2 (en) production process and compound